V
Exchange
UNKNOWN
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K177.1 KBViracta Therapeutics, Inc.Feb 5, 5:00 PM ET·0000950170-25-014630
- 8-K154.9 KBViracta Therapeutics, Inc.Jan 31, 4:30 PM ET·0000950170-25-011792
- 8-K287.1 KBViracta Therapeutics, Inc.Jan 24, 5:14 PM ET·0000950170-25-008889
- 8-K146.5 KBViracta Therapeutics, Inc.Jan 17, 4:08 PM ET·0000950170-25-006711
- 8-K173.2 KBViracta Therapeutics, Inc.Dec 26, 4:39 PM ET·0000950170-24-140446
- 8-K152.2 KBViracta Therapeutics, Inc.Nov 29, 5:14 PM ET·0000950170-24-131919
- 8-K151.0 KBViracta Therapeutics, Inc.Nov 22, 5:20 PM ET·0000950170-24-130294
- SC 13G/A266.7 KBViracta Therapeutics, Inc.Nov 14, 4:33 PM ET·0000921895-24-002727
- 10-Q7.8 MBViracta Therapeutics, Inc.Nov 13, 4:30 PM ET·0000950170-24-126385
- 8-K316.2 KBViracta Therapeutics, Inc.Nov 13, 7:30 AM ET·0000950170-24-125937
Insiders
10- ADELMAN DANIEL C MDSr. VP, Development and CMO
- Aisling Capital IV, LP10% Owner
- aMoon Growth Fund Limited Partnership10% Owner
- AUKEN WENDELL G VAN IIISee Explanation of Responses
- Barlow Jane FDirector
- BARRETT M JAMES10% Owner
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- Bay City Capital Fund V Co-Investment Fund, L.P.10% Owner
- Bay City Capital Fund V, L.P.10% Owner
Tickers
- VIRXUNKNOWN
Addresses
business
2533 S COAST HWY 101 SUITE 210
CARDIFF, CA, 92007
mailing
2533 S COAST HWY 101 SUITE 210
CARDIFF, CA, 92007
Former Names
- SUNESIS PHARMACEUTICALS INC2021-03-02